Thoracic CT-scanning follow-up of residual mediastinal masses after treatment of Hodgkin's disease
- PMID: 3353516
- DOI: 10.1016/0167-8140(88)90247-2
Thoracic CT-scanning follow-up of residual mediastinal masses after treatment of Hodgkin's disease
Abstract
Sequential thoracic CT-scanning was performed for 14 patients presenting with residual mediastinal masses on chest X-ray after treatment of stage I and II Hodgkin's disease (HD). Eleven patients initially presented with bulky mediastinal involvement. No mediastinal biopsy was performed. No local recurrence was detected at a 48 month median follow-up. Early evaluation by CT-scanning showed cystic degeneration in three cases. Sequential CT-scans on longer follow-up demonstrated continuous regression of residual masses in six cases and no or limited volume reduction in six other cases. In two patients, part of the residual mass remained stable and the other part showed reduction in size. In addition, late calcifications developed in four cases. The results of sequential CT-scanning suggest that residual mediastinal masses do not generally represent active disease. Hence additional, potentially toxic, therapy can be avoided.
Similar articles
-
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.Leuk Lymphoma. 1996 Jun;22(1-2):131-5. doi: 10.3109/10428199609051740. Leuk Lymphoma. 1996. PMID: 8724540 Clinical Trial.
-
The value of routine computed tomography scanning of the chest in patients presenting with supradiaphragmatic Hodgkin's disease.Australas Radiol. 1993 Aug;37(3):244-8. doi: 10.1111/j.1440-1673.1993.tb00065.x. Australas Radiol. 1993. PMID: 8373325
-
Outcome of residual mediastinal masses of thoracic lymphomas in children: impact on management and radiological follow-up strategy.Pediatr Radiol. 1998 Jun;28(6):444-50. doi: 10.1007/s002470050379. Pediatr Radiol. 1998. PMID: 9634459
-
Progressive mediastinal widening after therapy for Hodgkin's disease.Acta Clin Belg. 1995;50(5):282-7. doi: 10.1080/17843286.1995.11718462. Acta Clin Belg. 1995. PMID: 8533528 Review.
-
[Pulmonary cavitation as the initial manifestation of Hodgkin's disease].Med Clin (Barc). 1994 Sep 24;103(9):342-3. Med Clin (Barc). 1994. PMID: 7967895 Review. Spanish.
Cited by
-
[(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?Eur J Nucl Med Mol Imaging. 2003 May;30(5):682-8. doi: 10.1007/s00259-003-1120-6. Epub 2003 Feb 25. Eur J Nucl Med Mol Imaging. 2003. PMID: 12601498
-
Current role of gallium scanning in the management of lymphoma.Eur J Nucl Med. 1990;16(8-10):755-71. doi: 10.1007/BF00998184. Eur J Nucl Med. 1990. PMID: 2200680 Review.
-
Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients.Eur J Nucl Med Mol Imaging. 2003 Jun;30 Suppl 1:S97-105. doi: 10.1007/s00259-003-1166-5. Epub 2003 Apr 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 12709831 Review.
-
Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma.Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):22-8. doi: 10.1007/s00259-003-1333-8. Epub 2003 Oct 22. Eur J Nucl Med Mol Imaging. 2004. PMID: 14574514 Clinical Trial.
-
Radiotherapy for tumors of the mediastinum - state of the art.Kardiochir Torakochirurgia Pol. 2023 Dec;20(4):255-262. doi: 10.5114/kitp.2023.134132. Epub 2024 Jan 11. Kardiochir Torakochirurgia Pol. 2023. PMID: 38283558 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical